Page last updated: 2024-10-17

salicylic acid and Acute Coronary Syndrome

salicylic acid has been researched along with Acute Coronary Syndrome in 3 studies

Scalp: The outer covering of the calvaria. It is composed of several layers: SKIN; subcutaneous connective tissue; the occipitofrontal muscle which includes the tendinous galea aponeurotica; loose connective tissue; and the pericranium (the PERIOSTEUM of the SKULL).

Acute Coronary Syndrome: An episode of MYOCARDIAL ISCHEMIA that generally lasts longer than a transient anginal episode that ultimately may lead to MYOCARDIAL INFARCTION.

Research Excerpts

ExcerptRelevanceReference
"This study evaluated the association among the plasma concentration of ticagrelor, ARC124910XX, aspirin, and salicylic acid with the risk of recent bleeding in patients with the acute coronary syndrome."8.31The Plasma Concentration of Ticagrelor and Aspirin as a Predictor of Bleeding Complications in Chinese Acute Coronary Syndrome Patients With Dual Antiplatelet Therapy: A Prospective Observational Study. ( Guo, BY; Hao, J; Liu, JM; Ren, JL; Sun, YQ; Wang, CC; Yang, XL; Zhang, XR; Zhao, JJ; Zhao, Q, 2023)
"This study evaluated the association among the plasma concentration of ticagrelor, ARC124910XX, aspirin, and salicylic acid with the risk of recent bleeding in patients with the acute coronary syndrome."4.31The Plasma Concentration of Ticagrelor and Aspirin as a Predictor of Bleeding Complications in Chinese Acute Coronary Syndrome Patients With Dual Antiplatelet Therapy: A Prospective Observational Study. ( Guo, BY; Hao, J; Liu, JM; Ren, JL; Sun, YQ; Wang, CC; Yang, XL; Zhang, XR; Zhao, JJ; Zhao, Q, 2023)
"Acetylsalicylic acid (ASA) and clopidogrel combined therapy has been reported to be beneficial in patients with acute coronary syndrome (ACS)."3.85ABCC3 Polymorphisms and mRNA Expression Influence the Concentration of a Carboxylic Acid Metabolite in Patients on Clopidogrel and Aspirin Therapy. ( Bortolin, RH; Bravo, M; Brion, M; Carracedo, A; Concheiro, M; Cruz, A; Germano, JF; Hirata, MH; Hirata, RD; Iñiguez, A; López-Rivadulla, M; Luchessi, AD; Quintela, O; Silbiger, VN; Sousa, AG, 2017)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Araiza-Garaygordobil, D1
Gopar-Nieto, R1
Sierra-Lara Martínez, D1
Belderrain-Morales, N1
Sarabia-Chao, V1
Alfaro-Ponce, DL1
Ontiveros-Mercado, H1
Mendoza-García, S1
Altamirano-Castillo, A1
Martinez-Amezcua, P1
Cabello-López, A1
Briseño-De la Cruz, JL1
Ruiz-Beltrán, M1
Martínez-Ríos, MA1
Piña-Reyna, Y1
Gonzalez-Pacheco, H1
Arias-Mendoza, A1
Wang, CC1
Zhao, Q1
Guo, BY1
Hao, J1
Zhao, JJ1
Ren, JL1
Sun, YQ1
Zhang, XR1
Yang, XL1
Liu, JM1
Luchessi, AD1
Concheiro, M1
Germano, JF1
Silbiger, VN1
Bortolin, RH1
Cruz, A1
Quintela, O1
Brion, M1
Carracedo, A1
Iñiguez, A1
Bravo, M1
López-Rivadulla, M1
Hirata, RD1
Sousa, AG1
Hirata, MH1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Randomized Controlled Trial of Dual Antiplatelet Therapy Versus Antiplatelet Monotherapy and Oral Anticoagulation in Patients With Acute Coronary Syndrome and Coronary Artery Ectasia: OVER-TIME[NCT05233124]Phase 260 participants (Anticipated)Interventional2021-09-01Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for salicylic acid and Acute Coronary Syndrome

ArticleYear
Dual Antiplatelet Therapy Versus Antiplatelet Monotherapy Plus Oral Anticoagulation in Patients with Acute Coronary Syndrome and Coronary Artery Ectasia: Design and Rationale of OVER-TIME Randomized Clinical Trial.
    High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension, 2022, Volume: 29, Issue:5

    Topics: Acute Coronary Syndrome; Anticoagulants; Coronary Vessels; Dilatation, Pathologic; Drug Therapy, Com

2022

Other Studies

2 other studies available for salicylic acid and Acute Coronary Syndrome

ArticleYear
The Plasma Concentration of Ticagrelor and Aspirin as a Predictor of Bleeding Complications in Chinese Acute Coronary Syndrome Patients With Dual Antiplatelet Therapy: A Prospective Observational Study.
    Journal of cardiovascular pharmacology, 2023, 08-01, Volume: 82, Issue:2

    Topics: Acute Coronary Syndrome; Aspirin; East Asian People; Hemorrhage; Humans; Percutaneous Coronary Inter

2023
ABCC3 Polymorphisms and mRNA Expression Influence the Concentration of a Carboxylic Acid Metabolite in Patients on Clopidogrel and Aspirin Therapy.
    Basic & clinical pharmacology & toxicology, 2017, Volume: 120, Issue:5

    Topics: Acute Coronary Syndrome; Aged; Aspirin; Carboxylic Acids; Chromatography, Liquid; Clopidogrel; Cytoc

2017